CD274 and cancer: Additional immunosuppressive mechanisms employed by cancer cells include expression of immunomodulatory ligands (PD-L1, CD47 and CD155) that bind to corresponding cytotoxic T cells receptors (PD-1, SIRPα and TIGIT).